Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4028881011 | Product containing only tafasitamab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4028882016 | Tafasitamab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2858951000001113 | Tafasitamab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2858961000001111 | Tafasitamab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tafasitamab | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Tafasitamab | Is a | Product containing tafasitamab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Tafasitamab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Tafasitamab | Has active ingredient | Tafasitamab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Tafasitamab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only tafasitamab in parenteral dose form (medicinal product form) | Is a | True | Tafasitamab | Inferred relationship | Existential restriction modifier | |
| Tafasitamab 200mg powder for solution for infusion vials | Is a | True | Tafasitamab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR